Involvement of the dorsal hippocampus in mediation of the antianxiety action of tandospirone, a 5-hydroxytryptamine1A agonistic anxiolytic
- 31 May 1991
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 30 (5), 475-480
- https://doi.org/10.1016/0028-3908(91)90009-z
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Inhibition of hippocampal CA1 neurons by 5-hydroxytryptamine, derived from the dorsal raphe nucleus and the 5-hydroxytryptamine1A agonist SM-3997Neuropharmacology, 1990
- Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro.The Journal of Physiology, 1987
- Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmissionTrends in Pharmacological Sciences, 1987
- Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotoninNature, 1987
- Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brainSynapse, 1987
- Functional correlates of the subtypes of the 5-HT1 recognition siteTrends in Pharmacological Sciences, 1986
- Ipsapirone depresses neuronal activity in the dorsal raphe nucleus and the hippocampal formationEuropean Journal of Pharmacology, 1986
- 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition siteEuropean Journal of Pharmacology, 1983
- Précis ofThe neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal systemBehavioral and Brain Sciences, 1982
- The mammillary body is a potential site of antianxiety action of benzodiazepinesBrain Research, 1982